Search
Glembatumumab vedotin
go.drugbank.com/drugs/DB05996InvestigationalA conjugate of an anti-glycoprotein non-metastatic melanoma protein B mAb and monomethyl auristatin E for the treatment of melanoma and breast cancer.
Meclizine
go.drugbank.com/drugs/DB00737ApprovedInvestigationalMeclizine is a histamine H1 antagonist with antiemetic and antivertigo properties. It is used in the symptomatic treatment of motion sickness and control of vertigo associated with vestibular system diseases. It also exhibits anticholine...
Categories: Antihistamines for Systemic UseTiocarlide
go.drugbank.com/drugs/DB13608ExperimentalCategories: Antiinfectives for Systemic Use, Drugs for Treatment of TuberculosisExisulind
go.drugbank.com/drugs/DB06246InvestigationalCategories: Compounds used in a research, industrial, or household settingTalniflumate
go.drugbank.com/drugs/DB09295InvestigationalPhase I trials with talniflumate for the treatment of cystic fibrosis and COPD were completed in August 2001, and phase II trials were performed in Ireland for the treatment of cystic fibrosis but this … Talniflumate has been approved for approximately 20 years in Argentina other countries (excluding the United States, Europe, and Japan) [L1405].
Palmidrol
go.drugbank.com/drugs/DB14043InvestigationalNutraceuticalPalmidrol is available for human use as a supplement (400 mg capsules) and as food for medical purposes In Italy and Spain (300 mg and 600 mg tablets).
Brecanavir
go.drugbank.com/drugs/DB04887InvestigationalBrecanavir (VX-385) an orally active aspartic protease inhibitor (PI), under investigation by Vertex and GlaxoSmithKline for the treatment of HIV. … In December of 2006 GSK announced a decision to discontinue the development of brecanavir for the treatment of HIV. The decision was based on issues regarding the formulation of the drug.
Zoalene
go.drugbank.com/drugs/DB11480ExperimentalVet approvedDinitolmide is a fodder additive for prophylaxis against coccidiosis infections in poultry.
Adomeglivant
go.drugbank.com/drugs/DB11704InvestigationalAdomeglivant has been investigated for the basic science of Type 2 Diabetes.
Salanersen
go.drugbank.com/drugs/DB18418InvestigationalBIIB115 is an investigational antisense oligonucleotide in development for spinal muscular atrophy.